Literature DB >> 19567533

Infusing lipid raises plasma free fatty acids and induces insulin resistance in muscle microvasculature.

Zhenqi Liu1, Jia Liu, Linda A Jahn, Dale E Fowler, Eugene J Barrett.   

Abstract

CONTEXT: Insulin recruits muscle microvasculature, which increases the endothelial exchange surface area to facilitate substrate delivery. Elevated plasma concentrations of free fatty acids (FFAs) cause insulin resistance.
OBJECTIVES: The aim of the study was to examine whether FFAs cause insulin resistance in human muscle microvasculature.
SETTING: The study was conducted at the General Clinical Research Center at the University of Virginia.
METHODS: Twenty-two healthy subjects were studied under two protocols designed to raise plasma insulin concentrations to postprandial levels using either an insulin infusion or a mixed meal challenge. Within each protocol, subjects were studied twice. In random order, they received a 5-h systemic infusion of either saline or Intralipid/heparin. Three hours into the infusion, baseline muscle microvascular blood volume (MBV), microvascular flow velocity, and microvascular blood flow (MBF) were measured. Each subject was then given either the mixed meal or a 1 mU/kg x min insulin clamp for 2 h. Microvascular parameters were again obtained 2 h after the meal or at the end of insulin infusion.
RESULTS: Meal feeding and insulin infusion raised plasma insulin concentrations to approximately 200 pm, and each significantly increased muscle MBV (P = 0.03 and P < 0.01, respectively). MBF trended up after meal feeding (P = 0.08) and increased significantly after insulin infusion (P = 0.02). In the presence of Intralipid, neither the meal nor the insulin infusion increased muscle MBV and MBF.
CONCLUSIONS: Compared to saline, lipid infusion raises plasma FFA concentrations and blocks the ability of insulin or meal to recruit muscle microvasculature. High plasma FFA concentrations may contribute to muscle insulin resistance and the microvascular complications of diabetes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19567533      PMCID: PMC2741712          DOI: 10.1210/jc.2009-0027

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  36 in total

1.  Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells.

Authors:  G Zeng; F H Nystrom; L V Ravichandran; L N Cong; M Kirby; H Mostowski; M J Quon
Journal:  Circulation       Date:  2000-04-04       Impact factor: 29.690

2.  Lipid infusion impairs physiologic insulin-mediated capillary recruitment and muscle glucose uptake in vivo.

Authors:  Lucy H Clerk; Stephen Rattigan; Michael G Clark
Journal:  Diabetes       Date:  2002-04       Impact factor: 9.461

3.  Physiologic hyperinsulinemia enhances human skeletal muscle perfusion by capillary recruitment.

Authors:  M Coggins; J Lindner; S Rattigan; L Jahn; E Fasy; S Kaul; E Barrett
Journal:  Diabetes       Date:  2001-12       Impact factor: 9.461

4.  Insulin-mediated hemodynamic changes are impaired in muscle of Zucker obese rats.

Authors:  Michelle G Wallis; Catherine M Wheatley; Stephen Rattigan; Eugene J Barrett; Andrew D H Clark; Michael G Clark
Journal:  Diabetes       Date:  2002-12       Impact factor: 9.461

5.  Acute impairment of insulin-mediated capillary recruitment and glucose uptake in rat skeletal muscle in vivo by TNF-alpha.

Authors:  J M Youd; S Rattigan; M G Clark
Journal:  Diabetes       Date:  2000-11       Impact factor: 9.461

6.  Noninvasive quantification of coronary blood flow reserve in humans using myocardial contrast echocardiography.

Authors:  K Wei; M Ragosta; J Thorpe; M Coggins; S Moos; S Kaul
Journal:  Circulation       Date:  2001-05-29       Impact factor: 29.690

7.  Direct measurements of the permeability surface area for insulin and glucose in human skeletal muscle.

Authors:  Soffia Gudbjörnsdóttir; Mikaela Sjöstrand; Lena Strindberg; John Wahren; Peter Lönnroth
Journal:  J Clin Endocrinol Metab       Date:  2003-10       Impact factor: 5.958

8.  Mitochondrial reactive oxygen species generation in obese non-diabetic and type 2 diabetic participants.

Authors:  M A Abdul-Ghani; R Jani; A Chavez; M Molina-Carrion; D Tripathy; R A Defronzo
Journal:  Diabetologia       Date:  2009-01-30       Impact factor: 10.122

9.  Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects.

Authors:  Devjit Tripathy; Priya Mohanty; Sandeep Dhindsa; Tufail Syed; Husam Ghanim; Ahmad Aljada; Paresh Dandona
Journal:  Diabetes       Date:  2003-12       Impact factor: 9.461

10.  Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin.

Authors:  M A Vincent; E J Barrett; J R Lindner; M G Clark; S Rattigan
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-07       Impact factor: 4.310

View more
  57 in total

1.  Muscle microvascular recruitment predicts insulin sensitivity in middle-aged patients with type 1 diabetes mellitus.

Authors:  A Chan; E J Barrett; S M Anderson; B P Kovatchev; M D Breton
Journal:  Diabetologia       Date:  2011-12-14       Impact factor: 10.122

2.  Effects of oral and intravenous fat load on blood pressure, endothelial function, sympathetic activity, and oxidative stress in obese healthy subjects.

Authors:  Aidar R Gosmanov; Dawn D Smiley; Gonzalo Robalino; Joselita Siquiera; Bobby Khan; Ngoc-Anh Le; Riyaz S Patel; Arshed A Quyyumi; Limin Peng; Abbas E Kitabchi; Guillermo E Umpierrez
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-10-05       Impact factor: 4.310

Review 3.  Muscle microvasculature's structural and functional specializations facilitate muscle metabolism.

Authors:  Yvo H A M Kusters; Eugene J Barrett
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-12-29       Impact factor: 4.310

4.  Liraglutide prevents microvascular insulin resistance and preserves muscle capillary density in high-fat diet-fed rats.

Authors:  Weidong Chai; Zhuo Fu; Kevin W Aylor; Eugene J Barrett; Zhenqi Liu
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-07-19       Impact factor: 4.310

5.  Progressive hyperglycemia across the glucose tolerance continuum in older obese adults is related to skeletal muscle capillarization and nitric oxide bioavailability.

Authors:  Thomas P J Solomon; Jacob M Haus; Yanjun Li; John P Kirwan
Journal:  J Clin Endocrinol Metab       Date:  2011-02-02       Impact factor: 5.958

6.  Resveratrol recruits rat muscle microvasculature via a nitric oxide-dependent mechanism that is blocked by TNFα.

Authors:  Nasui Wang; Seung-Hyun Ko; Weidong Chai; Guolian Li; Eugene J Barrett; Lijian Tao; Wenhong Cao; Zhenqi Liu
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-10-26       Impact factor: 4.310

7.  Free fatty acids induce insulin resistance in both cardiac and skeletal muscle microvasculature in humans.

Authors:  Jia Liu; Linda A Jahn; Dale E Fowler; Eugene J Barrett; Wenhong Cao; Zhenqi Liu
Journal:  J Clin Endocrinol Metab       Date:  2010-11-03       Impact factor: 5.958

Review 8.  Exercise resistance across the prediabetes phenotypes: Impact on insulin sensitivity and substrate metabolism.

Authors:  Steven K Malin; Zhenqi Liu; Eugene J Barrett; Arthur Weltman
Journal:  Rev Endocr Metab Disord       Date:  2016-03       Impact factor: 6.514

9.  GLP-1 at physiological concentrations recruits skeletal and cardiac muscle microvasculature in healthy humans.

Authors:  Sharmila C Subaran; Matthew A Sauder; Weidong Chai; Linda A Jahn; Dale E Fowler; Kevin W Aylor; Ananda Basu; Zhenqi Liu
Journal:  Clin Sci (Lond)       Date:  2014-08       Impact factor: 6.124

10.  Effect of a sustained reduction in plasma free fatty acid concentration on insulin signalling and inflammation in skeletal muscle from human subjects.

Authors:  Hanyu Liang; Puntip Tantiwong; Apiradee Sriwijitkamol; Karthigayan Shanmugasundaram; Sumathy Mohan; Sara Espinoza; Ralph A Defronzo; John J Dubé; Nicolas Musi
Journal:  J Physiol       Date:  2013-03-25       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.